KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $1.6 billion.

  • Abbott Laboratories' Net Income towards Common Stockholders fell 12.15% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 billion, marking a year-over-year increase of 14236.17%. This contributed to the annual value of $13.4 billion for FY2024, which is 13417.79% up from last year.
  • As of Q3 2025, Abbott Laboratories' Net Income towards Common Stockholders stood at $1.6 billion, which was down 12.15% from $1.8 billion recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Net Income towards Common Stockholders registered a high of $9.2 billion during Q4 2024, and its lowest value of $1.0 billion during Q4 2022.
  • For the 5-year period, Abbott Laboratories' Net Income towards Common Stockholders averaged around $2.0 billion, with its median value being $1.6 billion (2023).
  • Per our database at Business Quant, Abbott Laboratories' Net Income towards Common Stockholders tumbled by 4785.46% in 2022 and then surged by 47898.37% in 2024.
  • Quarter analysis of 5 years shows Abbott Laboratories' Net Income towards Common Stockholders stood at $2.0 billion in 2021, then crashed by 47.85% to $1.0 billion in 2022, then soared by 54.31% to $1.6 billion in 2023, then soared by 478.98% to $9.2 billion in 2024, then tumbled by 82.19% to $1.6 billion in 2025.
  • Its Net Income towards Common Stockholders was $1.6 billion in Q3 2025, compared to $1.8 billion in Q2 2025 and $1.3 billion in Q1 2025.